L
LeMaitre Vascular
A provider of devices, implants and services for the treatment of peripheral vascular disease
About LeMaitre Vascular
LeMaitre is a global provider of innovative medical devices designed specifically for vascular surgeons. The company operates in the healthcare sector, focusing on the treatment of peripheral vascular disease. LeMaitre's core product, the LeMaitre Valvulotome, has significantly improved the treatment of lower extremity arterial disease by allowing surgeons to cut valves in peripheral veins without the need for direct vision. This innovation has led to the saving of 180,000 legs over the past decade.
LeMaitre serves a diverse range of clients, including hospitals, clinics, and specialized vascular surgery centers across 90 countries. The company's business model revolves around the research, development, and sale of high-quality vascular devices. Revenue is generated through the direct sale of these devices to healthcare providers and through distribution agreements in various regions.
The company has expanded its product portfolio to include aortic polyester vascular grafts, vascular allografts, occlusion catheters, AV access systems, collagen vascular grafts, and more. This diverse range of products ensures that LeMaitre can meet various needs within the vascular surgery field.
LeMaitre's commitment to innovation and quality has established it as a trusted name among vascular surgeons worldwide. The company's ongoing research and development efforts aim to further enhance the effectiveness and efficiency of vascular treatments.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Founded
- 1983
- Headquarters
- Burlington, United States
- Listing
- IPO 2006
- Employees
- 595
- Open positions
- 11
- Dealroom signal
- 55.0/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, observatoire healthtech
- Technology
- Hardware
- Business model
- Manufacturing
- Client focus
- b2b
- Investment activity
- 4 companies, latest Mar 2023
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| POST IPO CONVERTIBLE✓Other financing | Dec 2024 | $150M | — | Undisclosed | ↗ |
| POST IPO EQUITYOther financing | Jul 2021 | $55M | — | Undisclosed | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for LeMaitre Vascular is 4.2K monthly website visits, up 50% over the last three months. LeMaitre Vascular's team grew 72% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Restore Flow AllograftsChicago, United StatesRestore Flow Allografts is dedicated to researching the restorative transplantation of donated human tissue for medical treatment
$14Mvaluation
IN
InaveinLexington, United StatesLeMaitre Vascular, Inc. Acquires Inavein Redirection
$2.5Mvaluation
Vascular ArchitectsSan Jose, United StatesAnd markets devices to treat vascular disease and nonvascular obstructions
$2.8Mvaluation
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Other known investors1 additional known investor
Housatonic Partners
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about LeMaitre Vascular on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See LeMaitre Vascular’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







